A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and the modelling of cost-effectivenessan cost-utility for these groups in a UK context

• M Buxton,
• N Caine,
• D Chase,
• D Connelly,
• A Grace,
• C Jackson,
• J Parkes,
• L Sharples

Affiliations

M Buxton

N Caine

D Chase

D Connelly

A Grace

C Jackson

J Parkes

L Sharples

MRC Biostatistics Unit, Institute of Public Health, Cambridge, UK